# Prevention of Noise-induced Hearing Loss

> **NCT02049073** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Noise-induced Hearing Loss

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT02049073
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-31
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** new data makes this trial unethical
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049073, "Prevention of Noise-induced Hearing Loss". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02049073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*